Keyphrases
5-year Follow-up
14%
Active Rheumatoid Arthritis
14%
Adipocytokines
14%
Disease Activity
28%
Disease Activity Score
14%
Disease Progression
14%
Disease-modifying Antirheumatic Drugs (DMARDs)
100%
Drug Combination
28%
Early Disease
14%
Early Rheumatoid Arthritis
100%
Erosive Disease
100%
Human Macrophages
14%
Hydroxychloroquine
14%
Immunoassay
14%
In Vitro Study
14%
Inflammation
28%
Inflammatory Diseases
14%
Infliximab
100%
Insulin Resistance
14%
Methotrexate
14%
Nave
28%
Placebo
14%
Predictive Value
28%
Prednisolone
14%
Radiograph
14%
Radiographic Progression
42%
Resistin
100%
Resistin Levels
100%
Rheumatoid Arthritis
14%
Rheumatoid Arthritis Patients
14%
Score-based
14%
Sedimentation Rate
14%
Sulfasalazine
14%
THP-1 Macrophages
14%
Tumor Necrosis Factor Antagonist
14%
Tumor Necrosis Factor-α
42%
Medicine and Dentistry
Adipocytokine
11%
Combination Drug
22%
Disease
100%
Disease Activity
22%
Disease Activity Score
11%
Disease Exacerbation
11%
Disease Modifying Antirheumatic Drug
100%
Hydroxychloroquine
11%
Immunoassay
11%
In Vitro
11%
Inflammatory Disorder
11%
Infliximab
100%
Insulin Resistance
11%
Macrophage
22%
Methotrexate
11%
Placebo
11%
Prednisolone
11%
Resistin
100%
Rheumatoid Arthritis
100%
Salazosulfapyridine
11%
Tumor Necrosis
44%
Pharmacology, Toxicology and Pharmaceutical Science
Adipocytokine
11%
Combination Drug
22%
Disease
100%
Disease Activity
22%
Disease Activity Score
11%
Disease Exacerbation
11%
Disease Modifying Antirheumatic Drug
100%
Hydroxychloroquine
11%
Immunoassay
11%
Inflammation
22%
Inflammatory Disease
11%
Infliximab
100%
Insulin Resistance
11%
Methotrexate
11%
Placebo
11%
Prednisolone
11%
Resistin
100%
Rheumatoid Arthritis
100%
Sulfasalazine
11%
Tumor Necrosis
44%
Immunology and Microbiology
Adipokine
11%
Blood Plasma
11%
Disease-Modifying Antirheumatic Drug
100%
Hydroxychloroquine
11%
Immunoassay
11%
Inflammatory Arthritis
100%
Inflammatory Disorder
11%
Infliximab
100%
Insulin Resistance
11%
Macrophage
22%
Methotrexate
11%
Prednisolone
11%
Resistin
100%
Sedimentation Rate
11%
Sulfasalazine
11%
Tumor Necrosis Factor
44%